Comparison of pleural effusion features and biomarkers between talaromycosis and tuberculosis in non-human immunodeficiency virus-infected patients

Table 2 Concentrations of IL-23, IL-27, and IFN-γ in pleural effusion and serum

Variable	TMPE (n = 15)	TPE (n = 19)	P-value
IL-23
PE (pg/mL)	109.21 (57.74–222.04)	23.5 (11.6–28.8)	0.026 ^a
Serum (pg/mL)	100.11 (59.81–134.43)	54.79 (34.12–67.26)	0.024 ^a
IL-27
PE (pg/mL)	15.44 (11.42–19.12)	49.79 (35.9–81.5)	0.029 ^a
Serum (pg/mL)	1.49 (0.44–2.37)^a	1.26 (0.96–2.11)^a	0.078
IFN-γ
PE (pg/mL)	68.78 (48.4–89.5)	252.8 (156.5–310.8)	0.019 ^a
Serum (pg/mL)	6.45 (3.45–7.87)^a	5.19 (4.30–5.59)^a	0.458

Data are presented as median (25th–75th percentile)
ADA Adenosine deaminase, IFN Interferon, IL Interleukin, TMPE Talaromycosis pleural effusion, PE Pleural effusion, TPE Tuberculous pleural effusion
^a p < 0.05 means statistically significant. Compared with the corresponding value using analysis of variance followed by Wilcoxon rank sum test

ISSN: 1471-2334